Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Toray Industries divulges RORC antagonists

May 22, 2019

FLX Bio presents a novel CCR4 antagonist for the treatment of allergic disorders

May 21, 2019

Proof of concept achieved for KB-103 as topical treatment for epidermolysis bullosa dystrophica

May 17, 2019

Phase III study of abrocitinib in atopic dermatitis meets all coprimary and secondary endpoints

May 15, 2019

Sienna reports biopsy data from phase IIb study of SNA-120 for psoriasis

May 15, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

Connect Biopharma reports phase I data and new study in atopic dermatitis with CBP-201

May 6, 2019

European Commission approves Skyrizi for plaque psoriasis

May 2, 2019

Japanese phase III study of delgocitinib in pediatric atopic dermatitis meets primary endpoint

April 26, 2019

FDA approves Duobrii for plaque psoriasis

April 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...